|
1
|
Petersen SH, Harling H, Kirkeby LT,
Wille-Jørgensen P and Mocellin S: Postoperative adjuvant
chemotherapy in rectal cancer operated for cure. Cochrane Database
Syst Rev. 3:CD0040782012.
|
|
2
|
Collette L, Bosset JF, den Dulk M, Nguyen
F, Mineur L, Maingon P, Radosevic-Jelic L, Piérart M and Calais G:
Patients with curative resection of c T3-4 rectal cancer after
preoperative radiotherapy or radiochemotherapy: Does anybody
benefit from adjuvant fluorouracil-based chemotherapy? A trial of
the European organisation for research and treatment of cancer
radiation oncology group. J Clin Oncol. 25:4379–4386. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fietkau R, Barten M, Klautke G, Klar E,
Ludwig K, Thomas H, Brinckmann W, Friedrich A, Prall F, Hartung G,
et al: Postoperative chemotherapy may not be necessary for patients
with ypN0-category after neoadjuvant chemoradiotherapy of rectal
cancer. Dis Colon Rectum. 49:1284–1292. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hong YS, Nam BH, Kim KP, et al: Adjuvant
chemotherapy with oxaliplatin/5-fluorouracil/leucovorin (FOLFOX)
versus 5-fluorouracil/leucovorin (FL) for rectal cancer patients
whose postoperative yp stage 2 or 3 after preoperative
chemoradiotherapy: Updated results of 3-year disease-free survival
from a randomized phase II study (The ADORE). J Clin Oncol. 32
Suppl; Abstract no. 3502:5S2014.
|
|
5
|
Washington MK, Berlin J, Branton P,
Burgart LJ, Carter DK, Fitzgibbons PL, Halling K, Frankel W, Jessup
J, Kakar S, et al: Protocol for the examination of specimens from
patients with primary carcinoma of the colon and rectum. Arch
Pathol Lab Med. 133:1539–1551. 2009.PubMed/NCBI
|
|
6
|
Kaplan EMP: Nonparametric estimation from
incomplete observations. J Am Stat Assoc. 53:457–481. 1958.
View Article : Google Scholar
|
|
7
|
Mantel N: Evaluation of survival data and
two new rank order statistics arising in its consideration. Cancer
Chemother Rep. 50:163–170. 1966.PubMed/NCBI
|
|
8
|
Gill RD: Multistate life-tables and
regression models. Math Popul Stud. 3:259–276. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
André T, Boni C, Mounedji-Boudiaf L,
Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan
P, Bridgewater J, et al: Oxaliplatin, fluorouracil and leucovorin
as adjuvant treatment for colon cancer. N Engl J Med.
350:2343–2351. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wolmark N, Wieand S, Kuebler JP, et al: A
phase III trial comparing FULV to FULV+oxaliplatin in stage II or
III carcinoma of the colon: Results of NSABP Protocol C-07. J Clin
Oncol. 23 June 1 Suppl:LBA35002005. View Article : Google Scholar
|
|
11
|
Kuebler JP, Wieand HS, O'Connell MJ, Smith
RE, Colangelo LH, Yothers G, Petrelli NJ, Findlay MP, Seay TE,
Atkins JN, et al: Oxaliplatin combined with weekly bolus
fluorouracil and leucovorin as surgical adjuvant chemotherapyfor
stage II and III colon cancer: Results from NSABP C-07. J Clin
Oncol. 25:2198–2204. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
André T, Boni C, Navarro M, Tabernero J,
Hickish T, Topham C, Bonetti A, Clingan P, Bridgewater J, Rivera F
and de Gramont A: Improved overall survival with oxaliplatin,
fluorouracil and leucovorin as adjuvant treatment in stage II or
III colon cancer in the MOSAIC trial. J Clin Oncol. 27:3109–3116.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Haller DG, Tabernero J, Maroun J, de Braud
F, Price T, Van Cutsem E, Hill M, Gilberg F, Rittweger K and
Schmoll HJ: Capecitabine plus oxaliplatin compared with
fluorouracil and folinic acid as adjuvant therapy for stage III
colon cancer. J Clin Oncol. 29:1465–1471. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Park IJ, You YN, Agarwal A, Skibber JM,
Rodriguez-Bigas MA, Eng C, Feig BW, Das P, Krishnan S, Crane CH, et
al: Neoadjuvant treatment response as an early response indicator
for patients with rectal cancer. J Clin Oncol. 30:1770–1776. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bosset JF, Collette L, Calais G, Mineur L,
Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A and Ollier
JC: Chemotherapy with preoperative radiotherapy in rectal cancer. N
Engl J Med. 355:1114–1123. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fernández-Martos C, Pericay C, Aparicio J,
et al: Phase II, randomized study of concomitant chemoradiotherapy
followed by surgery and adjuvant capecitabine plus oxaliplatin
(CAPOX) compared with induction CAPOX followed by concomitant
chemoradiotherapy and surgery in magnetic resonance
imaging-defined, locally advanced rectal cancer: Grupo cancer de
recto 3 study. J Clin Oncol. 28:859–865. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Taylor MC, Pounder D, Ali-Ridha NH,
Bodurtha A and MacMullin EC: Prognostic factors in colorectal
carcinoma of young adults. Can J Surg. 31:150–153. 1988.PubMed/NCBI
|
|
18
|
Marble K, Banerjee S and Greenwald L:
Colorectal carcinoma in young patients. J SurgOncol. 51:179–182.
1992.
|
|
19
|
Cusack JC, Giacco GG, Cleary K, Davidson
BS, Izzo F, Skibber J, Yen J and Curley SA: Survival factors in 186
patients younger than 40 years old with colorectal adenocarcinoma.
J Am CollSurg. 183:105–112. 1996.
|
|
20
|
Li Q, Cai G, Li D, Wang Y, Zhuo C and Cai
S: Better long-term survival in young patients with non-metastatic
colorectal cancer after surgery, an analysis of 69,835 patients in
SEER database. PLoS One. 9:e937562014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
O'Connell JB, Maggard MA, Livingston EH
and Yo CK: Colorectal cancer in the young. Am J Surg. 187:343–348.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ben-Ishay O, Brauner E, Peled Z, Othman A,
Person B and Kluger Y: Diagnosis of colon cancer differs in younger
versus older patients despite similar complaints. Isr Med Assoc J.
15:284–287. 2013.PubMed/NCBI
|
|
23
|
Karsten B, Kim J, King J and Kumar RR:
Characteristics of colorectal cancer in young patients at an urban
county hospital. Am Surg. 74:973–976. 2008.PubMed/NCBI
|
|
24
|
Goodwin RA and Asmis TR: Overview of
systemic therapy for colorectal cancer. Clin Colon Rectal Surg.
22:251–256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chew MH, Koh PK, Ng KH and Eu KW: Improved
survival in an Asian cohort of young colorectal cancer patients: An
analysis of 523 patients from a single institution. Int J
Colorectal Dis. 24:1075–1083. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Serra-Rexach JA, Jimenez AB,
Garcia-Alhambra MA, Pla R, Vidán M, Rodríguez P, Ortiz J,
García-Alfonso P and Martín M: Differences in the therapeutic
approach to colorectal cancer in young and elderly patients.
Oncologist. 17:1277–1285. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nilsson PJ, van Etten B, Hospers GA, et
al: Short-course radiotherapy followed by neo-adjuvant chemotherapy
in locally advanced rectal cancer-the rapido trial. BMC Cancer.
13:2792013. View Article : Google Scholar : PubMed/NCBI
|
